iRhythm Technologies (LTS:0A7L) Debt-to-Equity : 8.16 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is iRhythm Technologies Debt-to-Equity?

iRhythm Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $15.3 Mil. iRhythm Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $721.7 Mil. iRhythm Technologies's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $90.3 Mil. iRhythm Technologies's debt to equity for the quarter that ended in Mar. 2024 was 8.16.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for iRhythm Technologies's Debt-to-Equity or its related term are showing as below:

LTS:0A7L' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.3 Med: 0.49 Max: 8.16
Current: 8.16

During the past 10 years, the highest Debt-to-Equity Ratio of iRhythm Technologies was 8.16. The lowest was -0.30. And the median was 0.49.

LTS:0A7L's Debt-to-Equity is ranked worse than
99.29% of 707 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs LTS:0A7L: 8.16

iRhythm Technologies Debt-to-Equity Historical Data

The historical data trend for iRhythm Technologies's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iRhythm Technologies Debt-to-Equity Chart

iRhythm Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.95

0.36

0.42

0.55

0.62

iRhythm Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.59	0.58	0.60	0.62	8.16

Competitive Comparison of iRhythm Technologies's Debt-to-Equity

For the Medical Devices subindustry, iRhythm Technologies's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iRhythm Technologies's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iRhythm Technologies's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where iRhythm Technologies's Debt-to-Equity falls into.

iRhythm Technologies Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

iRhythm Technologies's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(15.159	+	114.665)	/	210.097
	=	0.62

iRhythm Technologies's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(15.289	+	721.716)	/	90.29
	=	8.16

iRhythm Technologies (LTS:0A7L) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

iRhythm Technologies Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of iRhythm Technologies's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

iRhythm Technologies (LTS:0A7L) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRhythm Technologies Inc (LTS:0A7L) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

IRTC:USA

Address

699 8th Street, Suite 600, San Francisco, CA, USA, 94103

Website

https://www.irhythmtech.com

iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio include ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for up to 14 consecutive days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.

iRhythm Technologies (LTS:0A7L) Headlines

No Headlines